InvestorsHub Logo
Followers 16
Posts 1062
Boards Moderated 0
Alias Born 09/01/2019

Re: None

Wednesday, 06/24/2020 1:39:46 PM

Wednesday, June 24, 2020 1:39:46 PM

Post# of 16699
My opinion is that no excuses for management are necessary. The Progress has been Light speed compared to many/most clinical trials and advancements through regulators. Especially when coordinated to several countries.

Chris and Mark have made it a point to recognize the crews of subcontractors/assistance they are receiving help from. (paying for).

Certainly some low volume trades are doing their thing. Many have taken some early profits. THEY'RE shaking the TREES. Some are accumulating again/more on the possibilities they see.

Overall a lull and fair entrance point for any new investors. Long holders need to also determine their paths. Maybe some read a message board where extreme sentiments and opinions of expectations for a vocal few are not met. Oh well, this is a speculative micro pharma competing with Biggies. I'll express a positive scenario and mild speculation supported with current opinions/facts.

They did well on the needed 'raise' to finance the paths we're on, yet some struggles remain. Duh. COVID is Increasing in some newer infection areas and is certainly not under control. The need for Respiratory Treatments remains.

The science has obvious merit or else the Ethics applications would not be supported, world wide. AGN is 'jamming a foot in the doors' and coordinating Multinational Phase 2b/3 Clinical Trials thru the needed Government's. Not easy stuff and usually a much longer timeline is involved.
The 'Hype' may be wearing thinner but the Science is to be tested. Positive 'signals' with supporting data will be huge.
A FAIR Risk to Reward...JMO...
...GLTA...